Prof. Ulrika Simonsson, Ph.D.

Principal Director, MIDD Consultant & Senior Expert

Portrait-of-Ulrika-Simonsson-Pharmetheus-1

Bio

  • Co-founded Pharmetheus in 2012, actively working in client and internal projects/roles, serving as MIDD Consultant & Senior Expert
  • Expertise includes drug development using pharmacometrics, model-informed drug development, quantitative systems pharmacology and machine learning, with extensive experience in regulatory interactions and clinical pharmacology across different therapeutic areas
  • Experience as Professor of Pharmacokinetics at Uppsala University, Sweden, where she led a research group focusing on developing new antibiotics for tuberculosis treatment in collaboration with different pharmaceutical companies. Previously, Senior Research Scientist at AstraZeneca R&D Sweden, where she conducted pharmacometric analysis and supported trial design, and as Consultant at Pharsight Corporation, CA, USA, where she interacted with clients and provided pharmacometric support in client projects
  • M.Sc. in Pharmaceutical Sciences (1995) and Ph.D. in Pharmaceutical Biosciences (2000) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Exposure-Overall Survival Analysis for Quizartinib in Newly Diagnosed Patients with FMS- Like Tyrosine Kinase 3-Internal-Tandem-Duplication-Positive Acute Myeloid Leukemia